💰~$130K in insider buys reported by the CFO at Trisalus Life Sciences, $TLSI.

His ownership stake is up ~395%, with 12.5K of the 36.5K acquired shares added via grants (code "A").

Per Yahoo, the company "expects to achieve positive full-year EBITDA in 2025 and positive Cash Flow during the second half of 2025".
#TLSI